Yogeeswari Perumal, Sriram Dharmarajan, Thirumurugan Rathinasabapathy, Jeewanlal Logantha Ramamoorthy, Jit Sunil, Ragavendran Jegadeesan Vaigunda, Kavya Ramkumar, Rakhra Kavya, Saraswat Vivek
Medicinal Chemistry Research Laboratory, Pharmacy Group, Birla Institute of Technology and Science, Pilani-333031, India.
Acta Pharm. 2006 Sep;56(3):259-72.
Several 2,4-dimethylphenyl substituted semicarbazones were synthesized in three steps involving aryl urea and aryl semicarbazide formation. The structures were confirmed by spectral and elemental analyses. All the compounds were evaluated for anticonvulsant activity by using a series of test models, including maximal electroshock seizure, subcutaneous pentylenetetrazole and subcutaneous strychnine seizure threshold tests. The compounds were also evaluated for behavioural impairement and depression activity. In the neurochemical investigation, potent compounds were evaluated for their effects on rat brain gamma-aminobutyric acid (GABA) levels and in vitro gamma-aminobutyrate transaminase (Pseudomonas fluorescens) activity. Preliminary studies suggest that these compounds exhibit anticonvulsant activity via a GABA-mediated mechanism.
通过包括芳基脲和芳基氨基脲形成的三步反应合成了几种2,4-二甲基苯基取代的氨基脲。通过光谱和元素分析确定了其结构。使用一系列测试模型,包括最大电休克惊厥、皮下注射戊四氮和皮下注射士的宁惊厥阈值测试,对所有化合物的抗惊厥活性进行了评估。还对这些化合物的行为损伤和抑郁活性进行了评估。在神经化学研究中,对有效化合物对大鼠脑γ-氨基丁酸(GABA)水平和体外γ-氨基丁酸转氨酶(荧光假单胞菌)活性的影响进行了评估。初步研究表明,这些化合物通过GABA介导的机制表现出抗惊厥活性。